Suppr超能文献

小儿肾移植中急性和慢性排斥反应的组织病理学诊断

Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.

作者信息

Bröcker Verena, Mengel Michael

机构信息

Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

出版信息

Pediatr Nephrol. 2014 Oct;29(10):1939-49. doi: 10.1007/s00467-013-2640-3. Epub 2013 Oct 19.

Abstract

ABO-compatible as well as ABO-incompatible kidney transplantation are well established in the pediatric population. There are particularities in the histopathological evaluation of pediatric kidney transplant biopsies as for example the recurrence of certain diseases different from the adult population. Furthermore, the challenging transition of pediatric renal transplant recipients to adulthood is associated with an increased rate of non-adherence triggered rejection episodes. With modern immunosuppressive drugs, T-cell-mediated rejection of renal allografts is well controlled. In contrast, antibody-mediated rejection (AMR) is increasingly recognized as one of the major reasons for allograft loss. However, the 2001 diagnostic Banff criteria for antibody-mediated rejection require further refinement, as the morphological spectrum of AMR expands while effective therapeutic strategies are lacking. For example, endarteritis, which traditionally has been attributed to T-cell-mediated rejection, has recently been shown to be part of the AMR spectrum in some cases. Many findings in transplant renal biopsies are not specific for a certain disease but need consideration of differential diagnoses. To use the term "chronic allograft nephropathy" as a diagnostic entity is no longer appropriate. Therefore, the precise identification of specific diseases is paramount in the assessment of transplant renal biopsies in order to enable tailored therapeutic management.

摘要

ABO血型相容以及ABO血型不相容的肾移植在儿科人群中已得到充分确立。儿科肾移植活检的组织病理学评估存在一些特殊性,例如某些疾病的复发情况与成人不同。此外,儿科肾移植受者向成年期的艰难过渡与不依从引发的排斥反应发生率增加有关。使用现代免疫抑制药物后,肾移植受者中T细胞介导的排斥反应得到了很好的控制。相比之下,抗体介导的排斥反应(AMR)日益被认为是移植肾丢失的主要原因之一。然而,2001年抗体介导排斥反应的班夫诊断标准需要进一步完善,因为AMR的形态学范围在扩大,而有效的治疗策略却很缺乏。例如,传统上归因于T细胞介导排斥反应的动脉内膜炎,最近在某些病例中被证明是AMR范围的一部分。移植肾活检中的许多发现并非特定疾病所特有,而是需要考虑鉴别诊断。将“慢性移植肾肾病”作为一个诊断实体使用已不再合适。因此,在评估移植肾活检时,精确识别特定疾病对于实现针对性的治疗管理至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验